Cue Biopharma Inc (NAS:CUE)
$ 1.64 0.02 (1.23%) Market Cap: 79.78 Mil Enterprise Value: 51.26 Mil PE Ratio: 0 PB Ratio: 2.66 GF Score: 52/100

Q1 2021 Cue Biopharma Inc Earnings Call Transcript

May 17, 2021 / 08:30PM GMT
Release Date Price: $14 (+2.41%)
Operator

Thank you for standing by. This is the conference operator. Welcome to the Cue Biopharma First Quarter 2021 Earnings Call. (Operator Instructions)

And the conference is being recorded. (Operator Instructions)

I would now like to turn the conference over to Dr. George Zavoico, Vice President, IR and Corp. Development. Please go ahead.

George B. Zavoico
Cue Biopharma, Inc. - VP of IR & Corporate Development

Thank you, Shana. Good afternoon, everyone. Thank you for joining us. On today's call are Dan Passeri, Cue Biopharma's CEO; and Dr. Anish Suri, President and Chief Scientific Officer; Dr. Ken Pienta, Acting Chief Medical Officer; Dr. Matteo Levisetti, Senior Vice President of Clinical Development; and Kerri-Ann Millar, Chief Financial Officer. Next slide, please.

Before we begin, I would like to remind you that various remarks that the company makes during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot